These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38101474)
1. Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis. Angeletti A; Bin S; Magnasco A; Bruschi M; Cravedi P; Ghiggeri GM Am J Transplant; 2024 Apr; 24(4):688-692. PubMed ID: 38101474 [TBL] [Abstract][Full Text] [Related]
2. Reply to Angeletti et al-Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis. Dossier C; Hogan J Am J Transplant; 2024 Jul; 24(7):1325-1326. PubMed ID: 38387621 [No Abstract] [Full Text] [Related]
3. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis. Ino A; Kaori S; Takei T; Nitta K CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159 [TBL] [Abstract][Full Text] [Related]
4. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Yabu JM; Ho B; Scandling JD; Vincenti F Am J Transplant; 2008 Jan; 8(1):222-7. PubMed ID: 17979998 [TBL] [Abstract][Full Text] [Related]
11. Rituximab as a Preemptive Treatment to Prevent Recurrence of Primary Focal Segmental Glomerulosclerosis: A Novel Approach. El Khashab S; El Khashab O; El Ghoneimy M; AbdelRassoul MA Exp Clin Transplant; 2019 Jun; 17(3):326-329. PubMed ID: 30880653 [TBL] [Abstract][Full Text] [Related]
12. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis. Boonpheng B; Hansrivijit P; Thongprayoon C; Mao SA; Vaitla PK; Bathini T; Choudhury A; Kaewput W; Mao MA; Cheungpasitporn W World J Transplant; 2021 Jul; 11(7):303-319. PubMed ID: 34316454 [TBL] [Abstract][Full Text] [Related]
15. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab. Alachkar N; Li J; Matar D; Vujjini V; Alasfar S; Tracy M; Reiser J; Wei C BMC Nephrol; 2018 Dec; 19(1):361. PubMed ID: 30558559 [TBL] [Abstract][Full Text] [Related]
16. Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation. Al Shamsi HR; Shaheen I; Aziz D Transplant Rev (Orlando); 2022 Jan; 36(1):100675. PubMed ID: 34952298 [TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review. Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143 [TBL] [Abstract][Full Text] [Related]
18. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report. Kolonko A; Piecha G; Więcek A Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154 [TBL] [Abstract][Full Text] [Related]
19. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation. Kwon HE; Kim YH; Lee SA; Lee JJ; Ko Y; Shin S; Jung JH; Sung FS; Baek CH; Kim H; Park SK; Kwon H BMC Nephrol; 2023 Mar; 24(1):53. PubMed ID: 36922759 [TBL] [Abstract][Full Text] [Related]
20. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP; van de Kar NC; Wetzels JF Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]